Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer
Background and objective: Our aim was to provide a comprehensive analysis of the prevalence of potentially targetable activating FGFR3 alterations and their impact on oncological outcomes across different urothelial carcinoma (UC) stages. Methods: We retrospectively analyzed clinical data and FGFR3...
Saved in:
| Main Authors: | Maximilian Haas, Roman Mayr, Danijel Sikic, Bernd Wullich, Niklas Klümper, Philipp Erben, Ralph Wirtz, Christian Bolenz, Florian Roghmann, Robert Stöhr, Veronika Bahlinger, Arndt Hartmann, Maximilian Burger, Johannes Breyer, Markus Eckstein |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | European Urology Open Science |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168325001181 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1–4 mutated solid tumors
by: Jiyu Huang, et al.
Published: (2025-08-01) -
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
by: Niklas Klümper, et al.
Published: (2023-12-01) -
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development
by: Whi-An Kwon, et al.
Published: (2025-01-01) -
AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer
by: Pierre-Antoine Bannier, et al.
Published: (2024-12-01) -
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
by: Jinhao Chen, et al.
Published: (2025-03-01)